Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interventions for normal tension glaucoma.

T Sycha1, C Vass, O Findl

  • 1Department of Clinical Pharmacology, University of Vienna, Medical School, Allgemeines Krankenhaus Wien, Währinger-Gürtel 18-20, Vienna, Austria, A-1090.

The Cochrane Database of Systematic Reviews
|October 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren.

Hamostaseologie·2024
Same author

Retrospective Analysis of Prognostic Value of Optical Coherence Tomography Angiography for the Development of Glaucomatous Damage - One Year Follow-Up Retrospective Observational Cohort Analysis.

Klinische Monatsblatter fur Augenheilkunde·2023
Same author

Comparison of Neurovascular Coupling between Normal Tension Glaucoma Patients and Healthy Individuals with Laser Speckle Flowgraphy.

Current eye research·2020
Same author

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A.

Journal of thrombosis and haemostasis : JTH·2018
Same author

[Structural endpoints for glaucoma studies].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH).

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Treatments for normal tension glaucoma show mixed results. Lowering intraocular pressure may help, especially when accounting for cataracts, and calcium antagonists show promise for visual field loss.

Area of Science:

  • Ophthalmology
  • Clinical Trials
  • Glaucoma Research

Background:

  • Normal tension glaucoma (NTG) is characterized by optic nerve damage and visual field defects.
  • While intraocular pressure (IOP) is implicated, vascular factors are also considered in NTG progression.

Purpose of the Study:

  • To systematically review the efficacy of medical and surgical treatments for normal tension glaucoma.

Main Methods:

  • Included randomized controlled trials comparing interventions to control, placebo, or other treatments for NTG.
  • Two independent reviewers assessed trial eligibility and quality.
  • Data extraction and analysis were performed by two reviewers, with discrepancies resolved through discussion.

Main Results:

Related Experiment Videos

  • Eight studies met the visual field loss criteria; only three focused on patient-relevant outcomes.
  • Lowering IOP showed a potential benefit when data were adjusted for cataract development.
  • Two small studies indicated a positive effect of brovincamine (a calcium antagonist) on visual field loss.

Conclusions:

  • The benefit of IOP reduction on visual field outcomes in NTG was significant only after correcting for cataract development.
  • Calcium antagonists present promising results, but require validation through larger clinical trials.
  • Studies focusing solely on IOP reduction or hemodynamic variables may not directly translate to relevant outcomes in NTG patients.